Vanderbilt Therapeutics (VT) CRS

Nashville, Tennessee 37204

We've found

5 trials

at this facility

HIV-1-Gag Conserved-Element DNA Vaccine as Therapeutic Vaccination in HIV-Infected Persons With Viral Suppression on Antiretroviral Therapy

Status: Enrolling, Phase I, II
Updated: 12/31/1969

from

Nashville, TN

Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Nashville, TN

The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE

Status: Upcoming, Phase III
Updated: 12/31/1969

from

Nashville, TN

Pharmacokinetics of SAR441236

Status: Upcoming, Phase I
Updated: 12/31/1969

from

Nashville, TN

Safety and Immunotherapeutic Activity of an Anti-PD-1 Antibody (Cemiplimab) in HIV-1-infected Participants on Suppressive cART

Status: Upcoming, Phase I, II
Updated: 12/31/1969

from

Nashville, TN

Use our guide to learn which trials are right for you!